Hitting the Accelerator October 2020 Webinar
In recent times, the TGA has introduced a range of new prescription medicine application pathways that utilise overseas evaluations and accelerate market access. The team at Brandwood CKC have extensive experience with these new pathways and this webinar will outline the latest developments and provide insights as to the pros and cons of each pathway. A must for companies looking to accelerate Australian regulatory approvals and maximise efficiencies in the global rollout of new products.
Видео Hitting the Accelerator October 2020 Webinar канала Brandwood CKC
Видео Hitting the Accelerator October 2020 Webinar канала Brandwood CKC
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Traps for the unwary on quality systems – design controls before you manufacture
Biocompatibility Challenges for 2019
Market Access in Australia – leveraging international approvals for TGA registrations
Do I really need that clinical trial? A global approach to clinical evidence
Time to get serious on postmarket
Building a Technical File - Brandwood Biomedical Webinar
Medical Device Regulations Under COVID-19. What you need to know.
The Case For Quality
Harmonisation - Triumphs and Tragedies
Clinical Evaluation Report Webinar June 2020
Webinar (Feb 2017) Postmarket Compliance ISO 134852016 & New European Medical Device Regulations
Medical Device Software: Current Developments in the Regulatory World
Medical Device Sponsorship Requirements for Australia and New Zealand
BIOCOMPATIBILITY Webinar March 2020
Top FAQs for 2020
Blood, Sweat and Tears - An Update to In Vitro Diagnostics Regulatory Requirements World Wide
FDA and ISO stars aligning on ISO 10993
Documentation Deconstructed: Understanding the Technical file
Clinical Trials Down Under - Skipping regulatory approvals!
Why MDSAP opens a world of opportunity.